SYNDAX PHARMACEUTICALS, INC.

Organization

Waltham, MA, US

Ticker Symbols

NASDAQ:SNDX

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method of treating cancer using a combination of entinostat and an...
- Patent number 12,168,054
- Issue date Dec 17, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selection of patients for combination therapy
- Patent number 12,000,829
- Issue date Jun 4, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- G01 - MEASURING TESTING
Information Patent Grant
Inhibitors of the menin-MLL interaction
- Patent number 11,919,901
- Issue date Mar 5, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Gerard M. McGeehan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selection of patients for combination therapy
- Patent number 11,397,184
- Issue date Jul 26, 2022
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- G01 - MEASURING TESTING
Information Patent Grant
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment...
- Patent number 11,324,822
- Issue date May 10, 2022
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the treatment of breast cancer
- Patent number 10,226,472
- Issue date Mar 12, 2019
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING CHRONIC GRAFT-VERSUS-HOST DISEASE-RELATED BRONC...
- Publication number 20250011441
- Publication date Jan 9, 2025
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20240398944
- Publication date Dec 5, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE MENIN-MLL INTERACTION
- Publication number 20240400564
- Publication date Dec 5, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Salvacion CACATIAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20240288425
- Publication date Aug 29, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- G01 - MEASURING TESTING
Information Patent Application
COMBINATIONS FOR TREATMENT OF CANCER
- Publication number 20240238291
- Publication date Jul 18, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Gerald M. MCGEEHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF MENIN INHIBITORS AND CYP3A4 INHIBITORS AND METHODS...
- Publication number 20230165858
- Publication date Jun 1, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Gerard M. MCGEEHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20230061048
- Publication date Mar 2, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE
- Publication number 20230035183
- Publication date Feb 2, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20230022573
- Publication date Jan 26, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE MENIN-MLL INTERACTION
- Publication number 20230021684
- Publication date Jan 26, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Gerard M. MCGEEHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20210239697
- Publication date Aug 5, 2021
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES
- Publication number 20200171150
- Publication date Jun 4, 2020
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF BREAST CANCER
- Publication number 20190343844
- Publication date Nov 14, 2019
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...
- Publication number 20190290759
- Publication date Sep 26, 2019
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...
- Publication number 20180353602
- Publication date Dec 13, 2018
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- G01 - MEASURING TESTING
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20180252721
- Publication date Sep 6, 2018
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20180078639
- Publication date Mar 22, 2018
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF BREAST CANCER
- Publication number 20140378420
- Publication date Dec 25, 2014
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- G01 - MEASURING TESTING
Information Patent Application
ADMINISTRATION OF AN INHIBITOR OF HDAC
- Publication number 20130303575
- Publication date Nov 14, 2013
- SYNDAX PHARMACEUTICALS, INC.
- Konrad BURKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF LUNG CANCER
- Publication number 20130150386
- Publication date Jun 13, 2013
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gefitnib Sensitivity-Related Gene Expression and Products and Metho...
- Publication number 20120177641
- Publication date Jul 12, 2012
- SYNDAX PHARMACEUTICALS, INC.
- Paul A. BUNN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Administration of an Inhibitor of HDAC
- Publication number 20100305167
- Publication date Dec 2, 2010
- SYNDAX PHARMACEUTICALS, INC.
- Konrad Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Compounds and Methods of Using Them
- Publication number 20100298270
- Publication date Nov 25, 2010
- SYNDAX PHARMACEUTICALS, INC.
- John F.W. Keana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds and Methods of Using Them
- Publication number 20100267779
- Publication date Oct 21, 2010
- SYNDAX PHARMACEUTICALS, INC.
- John F.W. Keana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Administration of an Inhibitor of HDAC and an mTOR Inhibitor
- Publication number 20090149511
- Publication date Jun 11, 2009
- SYNDAX PHARMACEUTICALS, INC.
- Konrad Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR...
- Publication number 20080242648
- Publication date Oct 2, 2008
- Syndax Pharmaceuticals, Inc., a California Corporation
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
98423868 - SYNDACCESS
- Serial number 98423868
- Filing date Feb 27, 2024
- Syndax Pharmaceuticals, Inc.
- 36 - Insurance
Information Trademark
97760174 - TAYNREVU
- Serial number 97760174
- Filing date Jan 19, 2023
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97760175 - REVUFORJ
- Serial number 97760175
- Filing date Jan 19, 2023
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97760176 - REJVEDI
- Serial number 97760176
- Filing date Jan 19, 2023
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86916832
- Serial number 86916832
- Registration number 5863433
- Filing date Feb 23, 2016
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86453580 - ZOZENTI
- Serial number 86453580
- Filing date Nov 13, 2014
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86453583 - SYMVICTI
- Serial number 86453583
- Filing date Nov 13, 2014
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86453576 - TYDELAZ
- Serial number 86453576
- Filing date Nov 13, 2014
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86392710 - SYNDAX
- Serial number 86392710
- Registration number 4867989
- Filing date Sep 11, 2014
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85124983 - SYNDAX
- Serial number 85124983
- Registration number 4294113
- Filing date Sep 8, 2010
- Syndax Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
77759814 - TUMOR REPROGRAMMING
- Serial number 77759814
- Filing date Jun 15, 2009
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77032297 - SYNDAX
- Serial number 77032297
- Filing date Oct 30, 2006
- Syndax Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations

SYNDAX PHARMACEUTICALS, INC.

Organization

Ticker Symbols

Patents Grantslast 30 patents

Method of treating cancer using a combination of entinostat and an...

Selection of patients for combination therapy

Inhibitors of the menin-MLL interaction

Selection of patients for combination therapy

Combination of HDAC inhibitor and anti-PD-1 antibody for treatment...

Methods for the treatment of breast cancer

Patents Applicationslast 30 patents

METHODS OF TREATING CHRONIC GRAFT-VERSUS-HOST DISEASE-RELATED BRONC...

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

INHIBITORS OF THE MENIN-MLL INTERACTION

SELECTION OF PATIENTS FOR COMBINATION THERAPY

COMBINATIONS FOR TREATMENT OF CANCER

COMBINATIONS OF MENIN INHIBITORS AND CYP3A4 INHIBITORS AND METHODS...

SELECTION OF PATIENTS FOR COMBINATION THERAPY

ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

INHIBITORS OF THE MENIN-MLL INTERACTION

SELECTION OF PATIENTS FOR COMBINATION THERAPY

COMBINATION THERAPIES

METHODS FOR THE TREATMENT OF BREAST CANCER

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...

SELECTION OF PATIENTS FOR COMBINATION THERAPY

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

METHODS FOR THE TREATMENT OF BREAST CANCER

ADMINISTRATION OF AN INHIBITOR OF HDAC

METHODS FOR THE TREATMENT OF LUNG CANCER

Gefitnib Sensitivity-Related Gene Expression and Products and Metho...

Administration of an Inhibitor of HDAC

Novel Compounds and Methods of Using Them

Novel Compounds and Methods of Using Them

Administration of an Inhibitor of HDAC and an mTOR Inhibitor

COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR...

Trademarklast 30 trademarks

98423868 - SYNDACCESS

97760174 - TAYNREVU

97760175 - REVUFORJ

97760176 - REJVEDI

86916832

86453580 - ZOZENTI

86453583 - SYMVICTI

86453576 - TYDELAZ

86392710 - SYNDAX

85124983 - SYNDAX

77759814 - TUMOR REPROGRAMMING

77032297 - SYNDAX